These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 975073

  • 1. Retention of tritiated methotrexate in a transplantable mouse glioma.
    Tator CH.
    Cancer Res; 1976 Sep; 36(9 pt.1):3058-66. PubMed ID: 975073
    [Abstract] [Full Text] [Related]

  • 2. Intraneoplastic injection of methotrexate for experimental brain-tumor chemotherapy.
    Tator CH, Wassenaar W.
    J Neurosurg; 1977 Feb; 46(2):165-74. PubMed ID: 833633
    [Abstract] [Full Text] [Related]

  • 3. Glucose analogs as potential diagnostic tracers for brain tumors.
    Wassenaar W, Tator CH, Batty HP.
    Cancer Res; 1975 Mar; 35(3):785-90. PubMed ID: 1116133
    [Abstract] [Full Text] [Related]

  • 4. Chemotherapy of brain tumors. Uptake of tritiated methotrexate by a transplantable intracerebral ependymoblastoma in mice.
    Tator CH.
    J Neurosurg; 1972 Jul; 37(1):1-8. PubMed ID: 5037043
    [No Abstract] [Full Text] [Related]

  • 5. The uptake of tritiated methotrexate by an experimental glioma.
    Tator CH.
    Cancer Res; 1971 Nov; 31(11):1600-5. PubMed ID: 5121663
    [No Abstract] [Full Text] [Related]

  • 6. Distribution and degradation of [3H]methotrexate after intravenous and cerebral intraventricular injection in primates.
    Kimelberg HK, Biddlecome SM, Bourke RS.
    Cancer Res; 1977 Jan; 37(1):157-65. PubMed ID: 401470
    [Abstract] [Full Text] [Related]

  • 7. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
    Deguchi T, Chu TM, Leong SS, Horoszewicz JS, Lee CL.
    Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053
    [Abstract] [Full Text] [Related]

  • 8. Tumor and tissue distribution of a methotrexate-anti-EL4 immunoglobulin conjugate in EL4 lymphoma-bearing mice.
    Uadia P, Blair AH, Ghose T.
    Cancer Res; 1984 Oct; 44(10):4263-6. PubMed ID: 6467187
    [Abstract] [Full Text] [Related]

  • 9. Intratumoral methotrexate kinetics in a patient with intracranial anaplastic ependymoma.
    Geis T, Peters O, Friedrich M, Dränert E, Wolff JE.
    Pediatr Blood Cancer; 2004 Jul; 43(1):78-80. PubMed ID: 15170895
    [Abstract] [Full Text] [Related]

  • 10. Control of solid tumor metastases with a high-molecular-weight derivative of methotrexate.
    Chu BC, Whiteley JM.
    J Natl Cancer Inst; 1979 Jan; 62(1):79-82. PubMed ID: 281578
    [Abstract] [Full Text] [Related]

  • 11. Organ distribution of fibrinogen-bound methotrexate in mice with Gardner lymphosarcoma.
    Slavíková V, Dyr JE, Motycka K, Pristoupilová K, Holý P, Slavík K.
    Neoplasma; 1987 Jan; 34(3):269-76. PubMed ID: 3614463
    [Abstract] [Full Text] [Related]

  • 12. Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo.
    Poser RG, Sirotnak FM, Chello PL.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4441-6. PubMed ID: 6171339
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
    Shapiro WR, Voorhies RM, Hiesiger EM, Sher PB, Basler GA, Lipschutz LE.
    Cancer Res; 1988 Feb 01; 48(3):694-701. PubMed ID: 3335031
    [Abstract] [Full Text] [Related]

  • 14. The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors.
    Shapiro WR.
    Cancer Res; 1972 Oct 01; 32(10):2178-85. PubMed ID: 5080762
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
    Eleff M, Franks PE, Wampler GL, Collins JM, Goldman ID.
    Cancer Treat Rep; 1985 Oct 01; 69(7-8):867-74. PubMed ID: 2410122
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice.
    Kuehl M, Brixner DI, Broom AD, Avery TL, Blakley RL.
    Cancer Res; 1988 Mar 15; 48(6):1481-8. PubMed ID: 2449950
    [Abstract] [Full Text] [Related]

  • 17. Uptake of tritiated methotrexate by mouse brain tumors after intravenous or intrathecal administration.
    Ushio Y, Hayakawa T, Mogami H.
    J Neurosurg; 1974 Jun 15; 40(6):706-16. PubMed ID: 4406460
    [No Abstract] [Full Text] [Related]

  • 18. The effect of entrapment in liposomes on the in vivo distribution of [3H]methotrexate in a primate.
    Kimelberg HK, Tracy TF, Biddlecome SM, Bourke RS.
    Cancer Res; 1976 Aug 15; 36(8):2949-57. PubMed ID: 819137
    [Abstract] [Full Text] [Related]

  • 19. [Tissue concentration of methotrexate in osteosarcoma after high-dose infusion].
    Amino K.
    Nihon Seikeigeka Gakkai Zasshi; 1982 Aug 15; 56(8):765-76. PubMed ID: 6984057
    [Abstract] [Full Text] [Related]

  • 20. Uptake and distribution of 3 H-methotrexate by the murine ependymoblastoma.
    Levin VA, Clancy TP, Ausman JI, Rall DP.
    J Natl Cancer Inst; 1972 Apr 15; 48(4):875-83. PubMed ID: 4537157
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.